Stockscreener 앱 받기
0.3899
0.75%
0.0029
전일 마감가:
$0.387
열려 있는:
$0.384
하루 거래량:
22,203
Relative Volume:
0.02
시가총액:
$15.73M
수익:
$656.60K
순이익/손실:
$-16.79M
주가수익비율:
-0.3629
EPS:
-1.0743
순현금흐름:
$-11.12M
1주 성능:
+3.97%
1개월 성능:
+13.34%
6개월 성능:
-15.37%
1년 성능:
-79.90%
1일 변동 폭
$0.384
$0.3927
1주일 범위
$0.355
$0.3927
52주 변동 폭
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
명칭
Scienture Holdings Inc
전화
(800) 261 0281
주소
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, MEDS, POM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.3871 | 14.92M | 656.60K | -16.79M | -11.12M | -1.0743 |
HITI
High Tide Inc
|
2.365 | 187.16M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.979 | 42.10M | 179.02M | -57.29M | -33.01M | -2.7487 |
MEDS
Trxade Health Inc
|
3.21 | 7.84M | 7.15M | 4.03M | -11.33M | -5.40 |
POM
Pomdoctor Ltd Adr
|
0.658 | 5.38M | 0 | 0 | 0 | 0.00 |
Scienture Holdings Inc 주식(SCNX)의 최신 뉴스
Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Scienture Holdings Inc (SCNX) Cash Flow - TradingKey
When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable? - simplywall.st
Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scienture Holdings Inc (SCNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value to EBITDA forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture Holdings Inc (SCNX) Balance Sheet - TradingKey
Scienture Holdings Inc (SCNX) Income Statement - TradingKey
Scienture Holdings Inc (SCNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCNX|Scienture Holdings Inc|Price:0.370|Chg%:+0.001 - TradingKey
Scienture Holdings Inc (SCNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCNX|Scienture Holdings Inc|Price:0.372|Chg%:+0.003 - TradingKey
SCNX|Scienture Holdings Inc|Price:0.357|Chg%:-0.012 - TradingKey
Scienture Holdings Inc (SCNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DataMEDS AI Intends to Target GLP-1 Muscle Loss and Long COVID - Stock Titan
SCNX SEC FilingsScienture Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Scienture completes manufacturing for naloxone spray launch By Investing.com - Investing.com Nigeria
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionConsensus Beat Rate - dars.gov.et
$Scienture Holdings (SCNX.US)$ - Moomoo
Scienture Holdings stock jumps over 20% pre-market: Here's why - MSN
Scienture Holdings Company Profile & Introduction - Moomoo
Maxim Group Maintains Scienture Holdings(SCNX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX) - The Globe and Mail
Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why - Sahm
Scienture Holdings (SCNX) Registration filing Summary - Quartr
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Scienture Holdings, Inc. Completes Manufacturing of Commercial Launch Inventory and Begins Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Pharmaceutical Wholesalers - marketscreener.com
Scienture (SCNX) Prepares for Rezonopy Nasal Spray Launch - GuruFocus
Discover the top movers in Thursday's pre-market session. - ChartMill
Scienture completes manufacturing for naloxone spray launch - Investing.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers - marketscreener.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY (Naloxone Hydrochloride) to Wholesalers - Moomoo
Scienture readies highest-dose naloxone spray for August sale - Stock Titan
Scienture Holdings (SCNX) Slips 4% as Stock Tests Key Support Near $0.31Daily Profile - dars.gov.et
Scienture secures $11M debt financing for product launches - Investing.com
SCNX Q1 2026 Earnings: Significant EPS Beat Amid Pre-Revenue Stage as Scienture Outperforms Analyst ExpectationsEPS Surprise History - dars.gov.et
SCNX Q1 2026 Earnings: EPS Beat Narrower Losses, Shares SlideEarnings Beat Streak - dars.gov.et
Price to sales forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Price to book forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Price to earnings forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture Holdings, Inc. Actuals & Estimates (NASDAQ:SCNX) - TradingView
SCNX Q1 2026 Earnings: EPS Surprise of 64.35% Amid Revenue Silence; Stock Declines 1.42%Quarterly Earnings - dars.gov.et
SCNX Forecast — Price Target — Prediction for 2027 - TradingView
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-than-Expected Loss Fails to Lift Shares - dars.gov.et
Scienture Holdings Inc (SCNX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Scienture stock rises after adding 12.5M covered lives for Arbli - Investing.com Australia
Scienture stock rises after adding 12.5M covered lives for Arbli By Investing.com - Investing.com Australia
Scienture (SCNX) Advances Commercialization of Arbli - GuruFocus
Scienture expands payor coverage for Arbli by 12.5M lives - Investing.com
SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide - marketscreener.com
Scienture Holdings Inc (SCNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scienture Holdings Inc (SCNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.56%
1.55%
자본화:
|
볼륨(24시간):